Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
intraokulär lösning |
Is a |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Eye drops solution |
Is a |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
dexametasonnatriumfosfat 1,0 mg/ml, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
polymyxin B-sulfat 10 000 enheter + trimetoprimsulfat 1 mg, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ketorolac trometamol 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely azelastine hydrochloride 500 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
azitromycin 1 %, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Idoxuridine 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Sodium chloride 50 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ketorolac trometamol 4 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Sulfafurazole 40 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
moxifloxacinhydroklorid 0,5 %, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
trypanblått 1,5 mg/ml, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
ketorolaktrometamol 0,5 %, lösning utan konserveringsmedel för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Brimonidine tartrate 1.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
levofloxacin 5 mg/ml, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
trypanblått 0,06 %, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
oxibuprokainhydroklorid 0,4 % + fluoresceinnatrium 0,25 %, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely sodium chloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Unoprostone isopropyl 1.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Gentamicin sulfate 3 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
levofloxacin 1,5 %, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely bepotastine besilate 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timololmaleat 0,25 %, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely diclofenac sodium 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Tobramycin 3 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timololmaleat 0,5 %, gelbildande lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timololmaleat 0,25 %, gelbildande lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
feniramin 0,0315 %/nafazolin 0,02675 %, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timololmaleat 0,5 %, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Gatifloxacin 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Alcaftadine 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 80 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
norfloxacin 0,3 %, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
diklofenaknatrium 0,1 %, ögondroppar för engångsbruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
diklofenaknatrium 0,1 %, ögondroppar för flergångsbruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 100 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinhydroklorid 1 %, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinhydroklorid 2 %, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalin 2,0 %, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Adrenaline 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalin 1 %, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Naphazoline hydrochloride 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
prednisolonnatriumfosfat 1 %, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
fenylefrinhydroklorid 2,5 %, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dexamethasone 1 mg/mL cutaneous solution |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
prednisolonnatriumfosfat 1/8 %, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pemirolast potassium 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % + pilokarpinhydroklorid 1 %, vikt per volym, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % + pilokarpinhydroklorid 4 %, vikt per volym, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % + pilokarpinhydroklorid 6 %, vikt per volym, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % + pilokarpinhydroklorid 2 %, vikt per volym, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely naphazoline hydrochloride 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
kokainhydroklorid 2,5 %, ögondroppar, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
ketorolaktrometamol 0,5 %, ögondroppar, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
diklofenaknatrium 0,1 %, ögondroppar |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
kokainhydroklorid 10 %, ögondroppar, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
diklofenaknatrium 0,1 %, ögondroppar, lösning |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Sulfacetamide sodium 150 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Proparacaine hydrochloride 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Sulfacetamide sodium 200 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dipivefrine hydrochloride 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely sucrose 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Homatropine hydrobromide 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely flurbiprofen sodium 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely homatropine hydrobromide 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Chloramphenicol (as chloramphenicol sodium succinate) 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Homatropine hydrobromide 50 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Homatropine hydrobromide 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely boric acid 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Fluorescein sodium stain 2.5 mg/mL and proparacaine hydrochloride 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|